THE REALITY OF CONTINUOUS PHARMACEUTICAL MANUFACTURING
User experiences and the current status of continuous pharmaceutical processing to be addressed during a three-day event near Newcastle, UK
Taking place on 26–28 March 2019, GEA, Siemens and Perceptive Engineering will host an inaugural 3-day conference to examine the fact and fiction of Continuous Manufacturing (CM) in the pharmaceutical industry.
Hear from experts across the industry including AstraZeneca, Bayer, CMAC, GSK, Janssen, MSD, RCPE, UCB Pharma and University of Sheffield to name a few.
With an expected attendance of 80–120 delegates, this must-attend event will focus on the real-life experiences of existing users of CM technology in the development and manufacture of oral solid dosage (OSD) forms.
Contact Details:
Company name: GEA Group
Website: www.gea.com
E-mail: pharma@gea.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
